Insights

CMS raises the bar for MA plan quality ratings, CVS announces corporate layoffs, and California passes healthcare AI legislation. read more

With a projected 3.81% drug price inflation rate for pharmaceuticals by the Vizient Pharmacy Market Outlook, it's not surprising health system pharmacies are turning to formulary review as a way to m... read more

As Oct. 1 nears, so does the threat of strikes for U.S. East Coast and Gulf Coast ports. Here’s what you can do to prepare. read more

As the demand for emergency care and hospital beds — along with an aging population with more complex comorbidities — continues to increase, healthcare systems face what seem like insurmountable chal... read more

CMS releases results from the first round of Medicare Drug Price Negotiations, Steward finds a buyer for its physician group, and employers are using price transparency data in their suits against Ae... read more

Cellular and gene therapy — a rapidly growing field that involves modifying gene expression or cell properties for therapeutic purposes. read more

CVS to roll out co-located Oak Street Health clinics amid reduced profit outlook, CMS finalizes inpatient payment rule that includes new mandatory bundled payment model, and an appeals court gives pr... read more

Community Health Systems plans to sell its three Pennsylvania hospitals, a bankruptcy judge allows Steward Health Care to close two Massachusetts hospitals, and CMS approves North Carolina’s medical ... read more

The House Oversight Committee criticizes PBM pricing tactics, Humana’s CenterWell plans to open primary care centers at Walmarts, and a federal judge upholds the FTC’s noncompete rule, diverging from... read more

Novant cancels its plan to acquire two North Carolina hospitals from CHS amid an FTC challenge, Amazon expands its RxPass generic drug subscription service to Medicare, and the DOJ accuses two execut... read more